Centrally acting antihypertensives
Centrally acting antihypertensives reduce arteriolar muscular tone by reducing sympathetic activity.
First generation drugs, such as clonidine and methydopa, act as alpha-2 adrenoceptor agonists resulting in inhibition of the sympathetic nuclei in the rostroventrolateral medulla. Side-effects of these agents preclude their widespread use as first line hypertensive agents.
A second generation centrally-acting antihypertensive was subsequently introduced
- Moxonidine is an agonist at the imidazoline I1 receptor
- the I1 receptor is found in the rostroventrallateral medulla and in the kidney
- stimulation of I1 results in reduced sympathetic tone and a lowering of blood pressure
The summary of product characteristics should be consulted before prescribing this drug.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.